FN2 Earnings Intelligence

CME Group Inc. earnings overview

Latest CME Group Inc. (CME) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.

Next reportCME Group Inc. reports Wednesday, Oct 21, 2026 · Before market openConsensus EPS $2.96 · consensus revenue $1.71B
CME FY2026 Q2 · Calendar Q3 2026

CME Group Inc.

CME Group delivered record Q2 2026 revenue of $1.71B (+1.4% vs consensus) and EPS of $2.99 (+2.7% surprise), with near-historical daily contract volume driven by 94% institutional participation. The stock surged 5.0% on the print with continued positive drift of +4.3% afterward. Management maintained guidance and outlined a robust product pipeline: 24/7 crypto and gold futures, Single Stock futures, Compute Futures tied to NVIDIA H100 GPU rental costs, and Treasury Link for Q4 2026. Market-data revenue grew 20% YoY. The primary overhang is ongoing CFTC litigation, with the agency's response expected in August, creating uncertainty around 24/7 and perpetual futures offerings. The bullish score moderated to 78 from 88 last quarter, reflecting regulatory uncertainty and the absence of a capex outlook. With analyst consensus at $304 versus a current price of $260, the market is weighing…

EPS surprise+2.7%
Market move+5.0%
CME FY2026 Q1 · Calendar Q2 2026

CME Group Inc.

CME's quarter supports a constructive operating narrative: record activity, international growth and new clearing and digital products broaden its growth drivers. The counterweight is execution and regulatory risk, while the supplied analysis does not include prior-quarter analysis for a direct trend comparison.

EPS surprise+0.6%
Market move+0.5%
CME FY2025 Q3 · Calendar Q4 2025

CME Group Inc.

The supplied analysis supports a constructive but qualified view: strong activity, product innovation, retail expansion, and international demand provide growth support, while regulation, volatility, and execution remain material tests.

EPS surprise+1.9%
Market move-0.3%
CME FY2025 Q2 · Calendar Q3 2025

CME Group Inc.

The supplied analysis supports a constructive but qualified view: strong volume demand, retail participation and international growth reinforce CME’s earnings-growth narrative, while regulatory, macroeconomic and execution risks limit certainty.

EPS surprise+1.7%
Market move+0.7%

Get the CME recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.